H3 Biomedicine Inc., a cancer drug discovery company, has dedicated a new headquarters and 24,000 square feet of state-of-the-art laboratory space in Cambridge. Over the next year, the company plans to increase its staff to 70 people and further expand into more laboratory space within its building as it continues to pursue its mission to fulfill the promise of personalized cancer medicine.
